We can buy this stock at 3,24$, Relmada Therapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Gina DiGuglielmo (Vice President & Head-Clinical Operations), Maged S. Shenouda (Chief Financial Officer), Marco Pappagallo (Chief Medical Officer), Molly Harper (Executive Vice President-Operations), Paolo Manfredi (Chief Scientific Officer), Sergio Traversa (Chief Executive Officer & Director) and its address is 880 THIRD AVENUE 12TH FLOOR, NEW YORK, New York, 10022, United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 3,24$ moving between 3,13$ and 3,35$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The opening price that appears as last recorded is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
